Alex Petrides and Jonathan Petrides
James Noble
As co-founder and chief executive of Adaptimmunne, Noble is at the forefront of a field of healthcare that uses the body’s own immune system to fight cancer, HIV and infectious diseases. It is already testing its science on solid tumours, and listed on Nasdaq in 2015. Noble, 59, became full-time chief executive in 2014 after the company was split from Immunocore.
See Also
Maserati S.p.A.
Viale Ciro Menotti, 322 – 41121, Modena (MO), Italy
Company registered under Italian law - VAT: IT 08245890010 R.E.A. Modena 347990
Share capital: 80.000.000 €, fully paid-up
Direction and coordination under Article 2497 of the Italian Civil Code: Stellantis N.V.
maserati@pec.fcagroup.com
www.maserati.com
Find your local website
-
International
-
Africa
-
Europe
-
-
America
-
Asia
-
Middle-east
-
Oceania